Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical Trial.

Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical Trial. JAMA Netw Open. 2024 Jan 02; 7(1):e2350903.

View in: PubMed

subject areas

Adenocarcinoma
Humans
Male
Middle Aged
Neoadjuvant Therapy
Neoplasms, Second Primary
Organ Preservation
Rectal Neoplasms

authors with profiles

Blase Polite